Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function

Chime Biologics Enters into a Strategic Cooperation agreement with Korea Kings Pharm to Accelerate the Biosimilar Launch

Exciting Update! Explore Myrtelle’s Insightful Slide Presentation on Gene Therapy for Canavan Disease Preliminary One-Year Results from Meeting on the Mesa.

Here is the link to Alliance for Regenerative Medicine's Youtube Channel. Mark Hurtt gave a presentation last month at Mesa, here is the slideshow he presented with…